diabetes glp 1 Researchers find GLP-1 medications safe to continue before surgery in patients with and obesity The role of GLP1 receptor

Recent studies suggest that LC supplementation reduces inflammation in chronic kidney disease, cardiovascular disease, and neuroinflammation

doi: 10.1016/j.eclinm.2024.103029 6 BhardwajS.PathakK.McLenonM.SpectorS.TuK

Healthcare professionals should distinguish investigational practices from clinically validated therapeutic standards throughout all dosing discussions

Particular attention to dietary quality is warranted, especially in light of emerging and re-emerging nutritional deficiencies that may compromise immune function and exacerbate disease susceptibility

This happens because slower stomach emptying can cause food and acid to remain in the digestive tract longer, sometimes leading to cramping or reflux

10.1016/S2213-8587(17)30092-X 113